447 related articles for article (PubMed ID: 35964366)
1. Omicron BA.1 and BA.2 variants increase the interactions of SARS-CoV-2 spike glycoprotein with ACE2.
Golcuk M; Yildiz A; Gur M
J Mol Graph Model; 2022 Dec; 117():108286. PubMed ID: 35964366
[TBL] [Abstract][Full Text] [Related]
2. Electrostatic Interactions Are the Primary Determinant of the Binding Affinity of SARS-CoV-2 Spike RBD to ACE2: A Computational Case Study of Omicron Variants.
Sang P; Chen YQ; Liu MT; Wang YT; Yue T; Li Y; Yin YR; Yang LQ
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499120
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain.
Pitsillou E; Liang JJ; Beh RC; Hung A; Karagiannis TC
Comput Biol Med; 2022 Oct; 149():106035. PubMed ID: 36055162
[TBL] [Abstract][Full Text] [Related]
4. Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.
Niu S; Zhao Z; Liu Z; Rong X; Chai Y; Bai B; Han P; Shang G; Ren J; Wang Y; Zhao X; Liu K; Tian W-x; Wang Q; Gao GF
J Virol; 2024 Mar; 98(3):e0115723. PubMed ID: 38305152
[TBL] [Abstract][Full Text] [Related]
5. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
[TBL] [Abstract][Full Text] [Related]
6. Probing Mechanisms of Binding and Allostery in the SARS-CoV-2 Spike Omicron Variant Complexes with the Host Receptor: Revealing Functional Roles of the Binding Hotspots in Mediating Epistatic Effects and Communication with Allosteric Pockets.
Verkhivker G; Agajanian S; Kassab R; Krishnan K
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232845
[TBL] [Abstract][Full Text] [Related]
7. Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment.
Kumar S; Karuppanan K; Subramaniam G
J Med Virol; 2022 Oct; 94(10):4780-4791. PubMed ID: 35680610
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B.1.1.529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction studies.
Samanta A; Alam SSM; Ali S; Hoque M
Funct Integr Genomics; 2023 Jan; 23(1):36. PubMed ID: 36631570
[TBL] [Abstract][Full Text] [Related]
9. Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor.
Lupala CS; Ye Y; Chen H; Su XD; Liu H
Biochem Biophys Res Commun; 2022 Jan; 590():34-41. PubMed ID: 34968782
[TBL] [Abstract][Full Text] [Related]
10. Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants.
da Costa CHS; de Freitas CAB; Alves CN; Lameira J
Sci Rep; 2022 May; 12(1):8540. PubMed ID: 35595778
[TBL] [Abstract][Full Text] [Related]
11. Receptor binding domain of SARS-CoV-2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2.
Patil S; Alzahrani KJ; Banjer HJ; Halawani IF; Alzahrani H; Altayar MA; Albogami S; Angeles RF; Hassan AAA; Bhandi S; Raj AT
J Infect Public Health; 2022 Jul; 15(7):781-787. PubMed ID: 35738053
[TBL] [Abstract][Full Text] [Related]
12. Molecular Insights into the Variability in Infection and Immune Evasion Capabilities of SARS-CoV-2 Variants: A Sequence and Structural Investigation of the RBD Domain.
Wang TH; Shao HP; Zhao BQ; Zhai HL
J Chem Inf Model; 2024 Apr; 64(8):3503-3523. PubMed ID: 38517012
[TBL] [Abstract][Full Text] [Related]
13. Comparative Analysis of Conformational Dynamics and Systematic Characterization of Cryptic Pockets in the SARS-CoV-2 Omicron BA.2, BA.2.75 and XBB.1 Spike Complexes with the ACE2 Host Receptor: Confluence of Binding and Structural Plasticity in Mediating Networks of Conserved Allosteric Sites.
Alshahrani M; Gupta G; Xiao S; Tao P; Verkhivker G
Viruses; 2023 Oct; 15(10):. PubMed ID: 37896850
[TBL] [Abstract][Full Text] [Related]
14. Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy.
Ridgway H; Chasapis CT; Kelaidonis K; Ligielli I; Moore GJ; Gadanec LK; Zulli A; Apostolopoulos V; Mavromoustakos T; Matsoukas JM
Viruses; 2022 May; 14(5):. PubMed ID: 35632769
[TBL] [Abstract][Full Text] [Related]
15. Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2.
Gong SY; Ding S; Benlarbi M; Chen Y; Vézina D; Marchitto L; Beaudoin-Bussières G; Goyette G; Bourassa C; Bo Y; Medjahed H; Levade I; Pazgier M; Côté M; Richard J; Prévost J; Finzi A
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298733
[TBL] [Abstract][Full Text] [Related]
16. Exploring conformational landscapes and binding mechanisms of convergent evolution for the SARS-CoV-2 spike Omicron variant complexes with the ACE2 receptor using AlphaFold2-based structural ensembles and molecular dynamics simulations.
Raisinghani N; Alshahrani M; Gupta G; Xiao S; Tao P; Verkhivker G
Phys Chem Chem Phys; 2024 Jun; 26(25):17720-17744. PubMed ID: 38869513
[TBL] [Abstract][Full Text] [Related]
17. Insights into the structural peculiarities of the N-terminal and receptor binding domains of the spike protein from the SARS-CoV-2 Omicron variant.
Bayani F; Safaei Hashkavaei N; Uversky VN; Mozaffari-Jovin S; Sefidbakht Y
Comput Biol Med; 2022 Aug; 147():105735. PubMed ID: 35767919
[TBL] [Abstract][Full Text] [Related]
18. Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies.
Shah M; Woo HG
Front Immunol; 2021; 12():830527. PubMed ID: 35140714
[TBL] [Abstract][Full Text] [Related]
19. The Increased Amyloidogenicity of Spike RBD and pH-Dependent Binding to ACE2 May Contribute to the Transmissibility and Pathogenic Properties of SARS-CoV-2 Omicron as Suggested by In Silico Study.
Aksenova AY; Likhachev IV; Grishin SY; Galzitskaya OV
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362302
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody.
Omotuyi O; Olubiyi O; Nash O; Afolabi E; Oyinloye B; Fatumo S; Femi-Oyewo M; Bogoro S
Comput Biol Med; 2022 Mar; 142():105226. PubMed ID: 35066447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
